TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib

Cheng Lin; Chen Chen; Guiliu Huang; Yueyong Li; Lifeng Zhao; Zhongheng Wei

doi:10.5114/jcb.2023.131239

eISSN: 2081-2841
ISSN: 1689-832X

Journal of Contemporary Brachytherapy

Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links

Editorial System

Submit your Manuscript

4/2023
vol. 15

Send email

Copy url:

abstract:

Case report

TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib

Cheng Lin

¹

,

Chen Chen

¹

,

Guiliu Huang

²

,

Yueyong Li

¹

,

Lifeng Zhao

³

,

Zhongheng Wei

⁴

Interventional Ward of Oncology Department, Affiliated Hospital of Youjiang Medical College for Nationalities, Baise, Guangxi, China
Department of Gastroenterology, Affiliated Hospital of Youjiang Medical College for Nationalities, Baise, Guangxi, China
Chemotherapy Ward, Cancer Department, Affiliated Hospital of Youjiang Medical College for Nationalities, Baise, Guangxi, China
Academic Affairs Office of Youjiang Medical College for Nationalities, Baise, Guangxi, China

J Contemp Brachytherapy 2023; 15, 4: 283–289

DOI: https://doi.org/10.5114/jcb.2023.131239

Online publish date: 2023/08/31

View full text Get citation

Few cases of patients with Cheng’s type III portal vein tumor thrombus (PVTT) have been reported to achieve radical cure without recurrence over time. In this study, we reported on a 55-year-old male patient with a diagnosis of stage IIIa China liver cancer staging (CNLC), PVTT Cheng’s type III, mild cirrhosis, and chronic viral hepatitis B. TACE combined with radioactive iodine-125 (¹²⁵I) particle implantation was applied to achieve radical treatment with sequential oral anlotinib hydrochloride capsules. This case might serve as a reference for the treatment of this disease.

keywords:

TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib

Cheng Lin 1 , Chen Chen 1 , Guiliu Huang 2 , Yueyong Li 1 , Lifeng Zhao 3 , Zhongheng Wei 4

primary liver cancer, stage IIIa CNLC, trans-catheter arterial chemo-embolization, 125I

Cheng Lin

¹

,

Chen Chen

¹

,

Guiliu Huang

²

,

Yueyong Li

¹

,

Lifeng Zhao

³

,

Zhongheng Wei

⁴